AI can transform healthcare by improving diagnostic accuracy, personalising patient-care, and allowing for more efficient operations. As promising as it is, however, current research is limited in many ways including lack of validation on extensive scales, biases associated with AI, regulatory hurdles, scale, and privacy concerns. We call upon scientific community to participata on real-world clinical trials to re-train next-genAI to overcomes the above 3 challenges, hybrid bias detection algorithms to output of next-genAI, and scalable explainable models. This includes implementing AI-driven personalized medicine, predictive analytics, and remote patient monitoring systems to optimize patient outcomes and increase access to care. We enhance data privacy by implementing privacy-preserving methods including federated learning and homomorphic encryption. In addition, our framework emphasizes regulatory compliance, ensuring that AI healthcare solutions are ethical and legally viable. XAI will promote doctor-AI collaboration by ensuring transparency of AI model to instill trust in healthcare professionals. This paper proposes an all-in-one advanced solution for scaling AI applications globally in drug discovery, clinical research, and telemedicine. The ultimate goal of this research is to develop new AI-driven systems that are secure, transparent, and personalized, and that will foster a more effective, fair, and scalable healthcare system around the world.
Ramaiah et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: